PT - JOURNAL ARTICLE AU - Koffman, Jonathan AU - Penfold, Clarissa AU - Cottrell, Laura AU - Farsides, Bobbie AU - Evans, Catherine J AU - Burman, Rachel AU - Nicholas, Richard AU - Ashford, Stephen AU - Silber, Eli TI - “I wanna live and not think about the future” What place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study AID - 10.1101/2022.03.10.22272188 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.10.22272188 4099 - http://medrxiv.org/content/early/2022/03/16/2022.03.10.22272188.short 4100 - http://medrxiv.org/content/early/2022/03/16/2022.03.10.22272188.full AB - Background Little is known about how people with multiple sclerosis and their families comprehend advance care planning (ACP) and its relevance in their lives.Aim To explore under what situations, with whom, how, and why do people with MS and their families engage in ACPMethods We conducted a qualitative study comprising interviews with people living with MS and their families followed by an ethical discussion group with five health professionals representing specialties working with people affected by MS and their families. Twenty-seven people with MS and 17 family members were interviewed between June 2019 and March 2020. Interviews and the ethical discussion group were audio-recorded and transcribed verbatim. Data were analysed using the framework approach.Results Participants’ narratives focused on three major themes :(i) planning for an uncertain future; (ii) perceived obstacles to engaging in ACP that included uncertainty concerning MS disease progression, negative previous experiences of ACP discussions and prioritising symptom management over future planning; (iii) Preferences for engagement in ACP included a trusting relationship with a health professional and that information then be shared across services. Health professionals accounts from the ethical discussion group departed from viewing ACP as a formal document to that of an ongoing process of seeking preferences and values. They voiced similar concerns to people with MS about uncertainty and when to initiate discussions. Some shared concerns of a lack of confidence when having ACP discussions.Conclusion These findings support the need for a whole systems strategic approach where information about the potential benefits of ACP in all its forms can be shared with people with MS. Moreover, they highlight the need for health professionals to be skilled and trained in engaging in ACP discussions and where information is contemporaneously and seamlessly shared across services.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was generously funded by the MS Society [Grant code 93]. Professor Catherine Evans is funded by a Health Education England/ NIHR Senior Clinical Lectureship (ICA-SCL-2015-01-001). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute of Health Research or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Camden and Kings Cross Research Ethics Committee gave ethical approval for this work IRAS project ID 258274 REC reference ID 19/LO/0292 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying the results presented in the study are available from Professor Jonathan Koffman